Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.18 USD | -2.48% | +4.42% | -33.71% |
Mar. 14 | Transcript : Protalix BioTherapeutics, Inc., 2023 Earnings Call, Mar 14, 2024 | |
Mar. 14 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 74.06M | Sales 2025 * | 127M | Capitalization | 86.2M |
---|---|---|---|---|---|
Net income 2024 * | 17M | Net income 2025 * | 70M | EV / Sales 2024 * | 1.16 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.68 x |
P/E ratio 2024 * |
5.62
x | P/E ratio 2025 * |
1.46
x | Employees | 208 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.23% |
Latest transcript on Protalix BioTherapeutics, Inc.
1 day | -2.48% | ||
1 week | +4.42% | ||
Current month | -6.35% | ||
1 month | -3.28% | ||
3 months | -21.85% | ||
6 months | -22.37% | ||
Current year | -33.71% |
Managers | Title | Age | Since |
---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 57 | 19-06-29 |
Eyal Rubin
DFI | Director of Finance/CFO | 48 | 19-07-21 |
Yael Hayon
CTO | Chief Tech/Sci/R&D Officer | 41 | 20-07-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pol Boudes
BRD | Director/Board Member | 67 | 19-11-30 |
Gwen Melincoff
BRD | Director/Board Member | 72 | 19-11-30 |
Aharon Schwartz
BRD | Director/Board Member | 80 | 14-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.22% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.18 | -2.48% | 192,155 |
24-04-24 | 1.21 | +0.83% | 228,353 |
24-04-23 | 1.2 | +1.69% | 272,095 |
24-04-22 | 1.18 | +2.61% | 225,065 |
24-04-19 | 1.15 | +1.77% | 449,804 |
Delayed Quote Nyse, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.71% | 86.2M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+45.26% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- PLX Stock